NASDAQ

Sagimet Biosciences Inc. - Series A (SGMT)

♥ 315 Thanks from members

Live price chart, market sentiment, and community perspectives for Sagimet Biosciences Inc. - Series A (NASDAQ: SGMT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Tiziana Life Sciences (Predecessor roots)Founder: Sagimet TeamLeadership: David Armellini (CEO)Holder: Bioscience ManagersHolder: RA Capital ManagementDenifanstatFASN Inhibitors#SGMT#Sagimet Biosciences#Biotech#MASH Treatment#Denifanstat